Your browser doesn't support javascript.
loading
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
Yoon, D H; Ryu, M-H; Park, Y S; Lee, H J; Lee, C; Ryoo, B-Y; Lee, J-L; Chang, H-M; Kim, T W; Kang, Y-K.
Affiliation
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Br J Cancer ; 106(6): 1039-44, 2012 Mar 13.
Article in En | MEDLINE | ID: mdl-22343617
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Biomarkers, Tumor / Platinum Compounds / Drug Resistance, Neoplasm / Sirolimus / Fluorouracil / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2012 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Biomarkers, Tumor / Platinum Compounds / Drug Resistance, Neoplasm / Sirolimus / Fluorouracil / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2012 Document type: Article Country of publication: